Section Arrow
TNDM.NASDAQ
- Tandem Diabetes Care
Quotes are at least 15-min delayed:2026/03/11 22:16 EDT
Regular Hours
Last
 22.16
+0.29 (+1.33%)
Day High 
22.54 
Prev. Close
21.87 
1-M High
29.65 
Volume 
1.93M 
Bid
21.19
Ask
23.06
Day Low
21.145 
Open
21.57 
1-M Low
17.71 
Market Cap 
1.49B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 23.6 
20-SMA 22.44 
50-SMA 21.48 
52-W High 29.65 
52-W Low 9.98 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.04/-0.05
Enterprise Value
1.92B
Balance Sheet
Book Value Per Share
2.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.01B
Operating Revenue Per Share
11.29
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
MDTMedtronic plc88.97-0.92-1.02%25.14PE
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.